# Intellikine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/intellikine

- Industry: Pharmaceuticals
- Headquarters: US
- Website: www.intellikine.com
- Total disclosed funding: $94M
- Latest round: Series B (Jul 8, 2009)
- Investors on record: 7

## About

Intellikine is based in La Jolla, US and focuses on the development of innovative, small molecule therapies for the treatment of cancer, inflammation and autoimmune diseases.

## Funding rounds

- Series B, Jul 8, 2009, $51M — Abingworth, Sofinnova Investments, US Venture Partners, Novartis Venture Fund, Presidio Partners, BioGeneration Ventures, FGF Management
- Series A, Aug 15, 2007, $13M — Abingworth, Sofinnova Investments, Presidio Partners
- Series B, Jun 1, 2007, $30M — Sofinnova Investments

## Investors

- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series B, Series A
- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series A, Series B
- Presidio Partners (https://capitalatlas.ai/funds/presidio-partners) — Series A, Series B
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series B
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series B
- BioGeneration Ventures (https://capitalatlas.ai/funds/biogeneration-ventures) — Series B
- FGF Management (https://capitalatlas.ai/funds/fgf-management) — Series B